Tokyo Tape
Sign in
← Kirin Holdings

Half-year report · Q2

2503.TEDINET S100U68G
Period2024-01-01 → 2024-06-30
Filed2024-08-08
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥1.10T2024-01-01 → 2024-06-30Cons.Revenue IFRS
Revenue¥2.13T2023-01-01 → 2023-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥970.2bn2023-01-01 → 2023-06-30Cons.Revenue IFRS
Operating income¥80.9bn2024-01-01 → 2024-06-30Cons.Operating profit loss IFRS
Operating income¥36.9bn2023-01-01 → 2023-06-30Cons.Operating profit loss IFRS
Profit before tax¥108.5bn2024-01-01 → 2024-06-30Cons.Profit loss before tax IFRS
Profit before tax¥197.0bn2023-01-01 → 2023-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥57.1bn2023-01-01 → 2023-06-30Cons.Profit loss before tax IFRS
Net income (owners)¥57.2bn2024-01-01 → 2024-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥112.7bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥32.0bn2023-01-01 → 2023-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥74.2bn2024-01-01 → 2024-06-30Cons.Profit loss IFRS
Net income¥41.8bn2023-01-01 → 2023-06-30Cons.Profit loss IFRS
Total assets¥3.13Tat 2024-06-30Cons.Assets IFRS
Total assets¥2.87Tat 2023-12-31Cons.Assets IFRS
Total assets¥2.60Tat 2023-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥1.55Tat 2024-06-30Cons.Liabilities IFRS
Total liabilities¥1.44Tat 2023-12-31Cons.Liabilities IFRS
Net assets / equity¥1.59Tat 2024-06-30Cons.Equity IFRS
Net assets / equity¥1.43Tat 2023-12-31Cons.Equity IFRS
Net assets / equity¥1.33Tat 2023-06-30Cons.Equity IFRS
Net assets / equity¥1.25Tat 2022-12-31dCons.Equity IFRS
Equity (owners)¥1.29Tat 2024-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.13Tat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.06Tat 2023-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥138.4bnat 2024-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥131.4bnat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥140.0bnat 2023-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥88.1bnat 2022-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥108.7bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥203.2bn2023-01-01 → 2023-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥58.9bn2023-01-01 → 2023-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥116.0bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥226.1bn2023-01-01 → 2023-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥56.0bn2023-01-01 → 2023-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥21.6bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥35.9bn2023-01-01 → 2023-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥15.6bn2023-01-01 → 2023-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥70.652024-01-01 → 2024-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥139.162023-01-01 → 2023-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥39.52023-01-01 → 2023-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥70.652024-01-01 → 2024-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥139.152023-01-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥39.492023-01-01 → 2023-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio41.2%at 2024-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio39.5%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio40.8%at 2023-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-01-01 → 2024-06-30¥45.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-01-01 → 2024-06-30¥10.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-01-01 → 2024-06-30¥34.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-06-30−¥331m
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-06-30−¥38.5bn
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-06-30−¥38.5bn
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30−¥26.5bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue2024-01-01 → 2024-06-30¥513.7bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue external2024-01-01 → 2024-06-30¥512.5bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥1.2bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentsegment profit2024-01-01 → 2024-06-30¥50.3bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue2024-01-01 → 2024-06-30¥71.1bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue external2024-01-01 → 2024-06-30¥69.6bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥1.6bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentsegment profit2024-01-01 → 2024-06-30−¥1.6bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue2024-01-01 → 2024-06-30¥271.5bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue external2024-01-01 → 2024-06-30¥270.0bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥1.5bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentsegment profit2024-01-01 → 2024-06-30¥30.1bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue2024-01-01 → 2024-06-30¥233.0bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue external2024-01-01 → 2024-06-30¥232.8bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue intersegment2024-01-01 → 2024-06-30¥132m
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentsegment profit2024-01-01 → 2024-06-30¥41.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-01-01 → 2023-06-30¥44.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-01-01 → 2023-06-30¥13.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-01-01 → 2023-06-30¥31.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-01-01 → 2023-06-30−¥435m
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-06-30−¥36.1bn
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-06-30−¥36.1bn
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-06-30−¥24.0bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue2023-01-01 → 2023-06-30¥482.0bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue external2023-01-01 → 2023-06-30¥480.9bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentrevenue intersegment2023-01-01 → 2023-06-30¥1.0bn
jpcrp040300-q2r_E00395-000Alcoholic Beveragesreportable segmentsegment profit2023-01-01 → 2023-06-30¥45.0bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue2023-01-01 → 2023-06-30¥38.0bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue external2023-01-01 → 2023-06-30¥36.2bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentrevenue intersegment2023-01-01 → 2023-06-30¥1.8bn
jpcrp040300-q2r_E00395-000Health Sciencereportable segmentsegment profit2023-01-01 → 2023-06-30−¥4.4bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue2023-01-01 → 2023-06-30¥242.4bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue external2023-01-01 → 2023-06-30¥241.0bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentrevenue intersegment2023-01-01 → 2023-06-30¥1.4bn
jpcrp040300-q2r_E00395-000Non Alcoholic Beveragesreportable segmentsegment profit2023-01-01 → 2023-06-30¥23.0bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue2023-01-01 → 2023-06-30¥199.2bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue external2023-01-01 → 2023-06-30¥199.0bn
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentrevenue intersegment2023-01-01 → 2023-06-30¥210m
jpcrp040300-q2r_E00395-000Pharmaceuticalsreportable segmentsegment profit2023-01-01 → 2023-06-30¥36.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 831
ItemContextValueUnit
Other non current assets nca IFRSCurrentQuarterInstant43104000000JPY
Deferred tax assets IFRSPrior1YearInstant109322000000JPY
Deferred tax assets IFRSCurrentQuarterInstant107453000000JPY
Non current assets IFRSPrior1YearInstant1911764000000JPY
Non current assets IFRSCurrentQuarterInstant2117225000000JPY
Inventories ca IFRSPrior1YearInstant330984000000JPY
Inventories ca IFRSCurrentQuarterInstant375785000000JPY
Trade and other receivables ca IFRSPrior1YearInstant444940000000JPY
Trade and other receivables ca IFRSCurrentQuarterInstant439632000000JPY
Other financial assets ca IFRSPrior1YearInstant8944000000JPY
Other financial assets ca IFRSCurrentQuarterInstant7874000000JPY
Other current assets ca IFRSPrior1YearInstant37552000000JPY
Other current assets ca IFRSCurrentQuarterInstant52263000000JPY
Cash and cash equivalents IFRSPrior1YearInstant131399000000JPY
Cash and cash equivalents IFRSCurrentQuarterInstant138406000000JPY
Current assets other than assets held for sale ca IFRSPrior1YearInstant953818000000JPY
Current assets other than assets held for sale ca IFRSCurrentQuarterInstant1013961000000JPY
Assets held for sale IFRSPrior1YearInstant4004000000JPY
Assets held for sale IFRSCurrentQuarterInstant3724000000JPY
Current assets IFRSPrior1YearInstant957821000000JPY
Current assets IFRSCurrentQuarterInstant1017684000000JPY
Assets IFRSPrior1YearInstant2869585000000JPY
Assets IFRSCurrentQuarterInstant3134909000000JPY
Share capital IFRSPrior1YearInstant102046000000JPY
Share capital IFRSCurrentQuarterInstant102046000000JPY
Capital surplus IFRSPrior1YearInstant21150000000JPY
Capital surplus IFRSCurrentQuarterInstant13267000000JPY
Retained earnings IFRSPrior1YearInstant1128541000000JPY
Retained earnings IFRSCurrentQuarterInstant1155634000000JPY
Treasury shares IFRSPrior1YearInstant-251675000000JPY
Treasury shares IFRSCurrentQuarterInstant-251327000000JPY
Other components of equity IFRSPrior1YearInstant132519000000JPY
Other components of equity IFRSCurrentQuarterInstant270812000000JPY
Equity attributable to owners of parent IFRSPrior1YearInstant1132581000000JPY
Equity attributable to owners of parent IFRSCurrentQuarterInstant1290433000000JPY
Non controlling interests IFRSPrior1YearInstant293257000000JPY
Non controlling interests IFRSCurrentQuarterInstant297865000000JPY
Equity IFRSPrior1YearInstant1425838000000JPY
Equity IFRSCurrentQuarterInstant1588298000000JPY
Bonds and borrowings ncl IFRSPrior1YearInstant555725000000JPY
Bonds and borrowings ncl IFRSCurrentQuarterInstant605972000000JPY
Other financial liabilities ncl IFRSPrior1YearInstant82914000000JPY
Other financial liabilities ncl IFRSCurrentQuarterInstant88010000000JPY
Retirement benefit liability ncl IFRSPrior1YearInstant55228000000JPY
Retirement benefit liability ncl IFRSCurrentQuarterInstant55915000000JPY
Provisions ncl IFRSPrior1YearInstant4316000000JPY
Provisions ncl IFRSCurrentQuarterInstant4159000000JPY
Liabilities from application of equity method ncl IFRSPrior1YearInstant13966000000JPY
Liabilities from application of equity method ncl IFRSCurrentQuarterInstant11345000000JPY
Other non current liabilities ncl IFRSPrior1YearInstant19921000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-12-31pass
balance sheet identityconsolidated 2024-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-06-30pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-06-30pass
statement vs summary · revenueconsolidated 2023-01-01/2023-06-30pass
statement vs summary · revenueconsolidated 2024-01-01/2024-06-30pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-06-30pass